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Background: The feasibility of electrical impedance tomography (EIT) as an alternative examination tool in cystic ﬁbrosis (CF) was examined.
Methods: 14 CF patients and 14 healthy volunteers were studied. Spirometry and EIT measurements were performed simultaneously. The global
inhomogeneity (GI) index was applied to assess the degree of ventilation homogeneity at different levels of maximum inspiratory volume. Ratios of
maximum expiratory ﬂow at 25% and 75% of vital capacity (MEF25/MEF75) were calculated for both global lung and regional areas in EIT images.
Results: Signiﬁcant differences among GI values at various lung volumes were found in CF patients (Pb0.01) but not in healthy subjects. Global
MEF25/MEF75 measured with spirometry and with EIT were highly correlated for all subjects (r
2=0.69, Pb0.01). Signiﬁcant difference in global
MEF25/MEF75 was found between CF patients and healthy volunteers with both spirometer (CF: 0.15±0.09; healthy: 0.46±0.15; Pb0.001) and
EIT (CF: 0.14±0.09; healthy: 0.42±0.08; Pb0.001). Regional airway obstruction was identiﬁed in the MEF25/MEF75 maps in CF patients.
Conclusions: Compared to the global parameters provided by spirometry, EIT is able to deliver both global and regional information to assess the
airway obstruction in CF patients.
© 2012 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Cystic ﬁbrosis; Electrical impedance tomography; Lung function test; Ventilation homogeneity1. Background
Cystic fibrosis (CF) is an inherited, chronic disease that
mainly affects the lungs and the digestive system. It is caused
by a mutation in the cystic fibrosis transmembrane conductance
regulator (CFTR) gene [1]. Unfortunately, there is still no cure
for CF and it tends to increase in severity over time [2]. Despite☆ The results of this study have been presented in part at the 12th International
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(4–6, May) and the 5th International Conference on Bioinformatics and
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doi:10.1016/j.jcf.2012.03.011improved treatments, CF patients only have a mean survival
time of 37 years [3].
The alteration of lung structure and small airways leads to
flow reduction during inspiration and expiration [4,5]. A spi-
rometer measures global parameters such as forced expiratory
volume in 1 second (FEV1) and maximum expiratory flow at
25%, 50% and 75% of vital capacity (MEF25, MEF50, MEF75)
from which the degree of airway obstruction can be implied.
However, information on regional ventilation cannot be
captured with these global parameters. In order to recognize
an exacerbation early and more precisely, imaging techniques
such as conventional radiography and computed tomography
(CT) are employed. CT is considered a gold standard for
assessment of aeration in injured lungs [6]. Unfortunately, due
to high radiation exposure, CT is inadequate for long term
monitoring of disease progression.by Elsevier B.V. All rights reserved.
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proposed to evaluate ventilation inhomogeneity in CF patients,
[7,8]. Though this technique is more sensitive than FEV1 and
MEF25 in early diagnosis of CF, it is not able to detect regional
changes in early CF lung disease. This is due to the fact the
both MBWT and spirometry are assessed at the mouth of the
patients wich represents the last end of the airways. Therefore,
any detection of regional changes in early CF lung disease
might be masked by the inevitable dilution of regional air flow
from all lung sites. A direct, radiation-free assessment of
regional lung ventilation might therefore demonstrate additional
information in early CF lung disease or during exacerbations.
Electrical impedance tomography (EIT) is a noninvasive,
radiation-free imaging technique which can monitor regional
lung ventilation and tidal volume distribution by measuring the
electrical potentials at the chest wall surface. The rationale is
that changes in regional air content and regional blood volume
modify the electrical impedance of lung tissue [9,10]. The
reliability of EIT has already been confirmed by comparison
with different conventional methods including CT and
pneumotachography [11-13]. Applications of EIT have been
proposed in subjects without lung disease [14-16] and in
patients with mild, moderate, and severe lung diseases [17-19]
to assess the ventilation distribution or even guiding respiratory
therapies. However, there exists no EIT study in CF patients up
to now. The aim of this pilot study was to examine the
feasibility of EIT as an alternative clinical examination tool for
CF patients. In order to be an alternative clinical tool, EIT
should be able to deliver: 1) reliable information comparable
with spirometry; 2) additional information about the lung
dynamics and ventilation distribution (information gain). In the
present study, we compared the EIT findings with spirometry
according to these two criteria.2. Material and methods
2.1. Protocol and measurement
A total of 14 CF patients (CF group: 6 male, 8 female; age
34±9 years; height 166±9 cm; weight 56±8 kg (mean±SD))
and 14 lung healthy volunteers (control group: 8 male, 6
female; age 28±7 years; height 171±10 cm; weight 71±20 kg
(mean±SD)) were studied prospectively. Exclusion criteria
included age b18 years, pregnancy and lactation period, and
any contraindication to the use of EIT (pacemaker, automatic
implantable cardioverter defibrillator, and implantable pumps).
An additional exclusion criterion for the control group was
history or clinical signs of lung disease. The study was
approved by the Ethics Committee of the University of
Munich. Written informed consent was obtained from all
patients and healthy subjects prior to the study.
All subjects were seated during the complete measurement.
After a stabilization period of 2 min, they were asked to breath
in as deep and exhale as hard as possible for three times at the
spirometer (MasterLab, Inc. Carefusion, Höchberg, Germany),
according to standard spirometry guidelines from the AmericanThoracic Society and European Respiratory Society [20]. This
process was repeated once for every subject.
An EIT electrode belt with 16 electrodes was placed around
the thorax in the fifth intercostal space and one reference
electrode was placed at the patients’ abdomen (EIT Evaluation
KIT 2, Dräger Medical, Lübeck, Germany). After applying
electrical alternating currents (50 kHz, 5 mA peak-to-peak) in a
sequential rotating process and measuring the resulting surface
potential differences between neighboring electrode pairs, EIT
images (each consisting of 32×32 pixels) were generated with
a reconstruction algorithm based on a modified ‘finite element
model’ [21]. EIT images were continuously measured at 20 Hz
during lung function test.2.2. Data evaluation
A so-called global inhomogeneity (GI) index based on EIT
was recently introduced by our group to quantify the tidal
volume distribution within the lung [16,22]. In the present
study, the GI index was slightly modified to evaluate the
inhomogeneity degree at 25%, 50%, 75% and 100% of
maximum inspiratory volume. For every forced inspiration,
four difference images, which represented the respective
differences of impedance between 25%, 50%, 75%, 100% of
maximum inspiratory volume and inspiration begin (0%), were
generated. Lung regions in EIT images were defined using the
LAE method [23]. The median value of the pixels in the lung
area was calculated for each difference image. The GI index
was defined as the sum of the absolute differences between the
median value and every pixel value, which was normalized
with the sum of the impedance values within the lung area:
GI ¼
∑
x;y∈lung
DIxy−Median DIlung
  
∑
x;y∈lung
DIxy
ð1Þ
where DI is the value of the differential impedance in the
difference images; DIxy denotes the pixel in the identified lung
area; DIlung are all pixels in the lung area under observation.
The GI index values at the levels of 25%, 50%, 75% and 100%
are denoted as GI25, GI50, GI75 and GI100, respectively.
Coefficient of variation for within-subject GI was calculated
for both groups to assess the repeatability.
The total relative impedance values (Irel) are proportional to
inspiratory and expiratory volumes [13], derivatives of Irel
(I´rel) are considered to be proportional to inspiratory and
expiratory flows. Since EIT delivers only relative impedance
values, a direct comparison with spirometric parameters is not
possible. Therefore, the ratios of maximum expiratory flows at
25% and 75% of vital capacity (MEF25/MEF75) during forced
expiration were calculated both for the global sum of
impedance values, and for every pixel of lung regions in the
EIT images. MEF25/MEF75 values derived from EIT were
compared to that obtained from spirometry tests for validation.
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Data analysis was performed using MATLAB 7.2 (The
MathWorks Inc., Natick, MA, USA). The Lilliefors test was
used for normality testing. For not normally distributed data,
results were expressed as median (interquartile range) or lower
and upper quartiles. Kruskal–Wallis test was performed to
compareGI25,GI50,GI75 andGI100. Post-hoc paired comparisons
were performed with the paired-sample Wilcoxon signed rank
test and the significant levels were corrected using the Holm's
sequential Bonferroni method for multiple comparisons. Data
are reported when a ≥20% difference existed between variables.
In case of normal distribution, results were expressed as mean
values±SD. Global MEF25/MEF75 values in CF patients and
healthy subjects were compared with an unpaired t-test. A
P valueb0.05 was considered statistically significant. The fre-
quency distribution of regional MEF25/MEF75 was described
with histograms.
3. Results
All subjects were able to complete the procedure. The data
evaluation described in the last section was performed on all
measurements. Figs. 1 and 2 show the difference images of a
healthy volunteer and a CF patient at different preselected lung
volume levels of the forced breathing cycle. Air distribution is
similar at all levels in the healthy subject (Fig. 1) while more air
is distributed to the right dorsal regions of the CF patient
compared to the right ventral regions at 25% and 50% of the
maximum inspiratory volume (Fig. 2). Ventilation distributionFig. 1. Difference images of one subject with healthy lungs at (a) 25%, (b) 50%, (c) 7
indicate the magnitude of relative impedance values in each pixel.becomes more homogeneous at higher inspiratory volume
levels in this patient, which indicates that the airways are
partially obstructed leading to a delay in air distribution.
However, the difference between the healthy subject and the
CF patient is not obvious when only comparing the EIT images.
Information on regional ventilation distribution was extracted
by calculating the GI index. The median (interquartile range)
coefficient of variation for within-subject GI was 6.2 (2.0)% for
CF patients and 5.2 (3.0)% for healthy volunteers. In Fig. 3, the
GI index at different lung volume levels during forced inspiration
are depicted and compared in both CF and control groups.
Significantly different GI values at various lung volume levels
were found in the CF group (fromGI25 toGI100: 0.49 (0.25), 0.38
(0.14), 0.36 (0.12) and 0.34 (0.09), median (interquartile range);
Pb0.01) but not in the control group (from GI25 to GI100: 0.39
(0.07), 0.35 (0.04), 0.35 (0.03) and 0.35 (0.03)). Further, GI25
was 20% greater than GI100 in CF patients (relative to GI100,
Pb0.01).
Global flow-volume curves from one CF patient with
spirometry and EIT (top), together with regional flow-volume
curves with EIT (bottom) were plotted exemplarily in Fig. 4.
Shape of regional flow-volume curves differed from that of the
global ones. Spirometric parameters from CF patients and
healthy volunteers were compared in Table 1. MEF25/MEF75
values measured with spirometer and with EIT were highly
correlated for all 28 subjects (r2 =0.69, Pb0.01). Significant
difference in MEF25/MEF75 was found between CF group and
control group with both spirometer (CF group: 0.15±0.09;
control group: 0.46±0.15; Pb0.001) and EIT (CF group: 0.14±
0.09; control group 0.42±0.08; Pb0.001).5% and (d) 100% of maximum inspiratory volume (difference to 0%). Color bars
Fig. 2. Difference images of one CF patient at (a) 25%, (b) 50%, (c) 75% and (d) 100% of maximum inspiratory volume (difference to 0%). Color bars indicate the
magnitude of relative impedance values in each pixel.
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the lung areas of the EIT images. Typical results in a healthy
subject (Fig. 5, left) and a CF patient (Fig. 5, right) are plotted
in two images with a resolution of 32×32 pixels. Note that the
pixel values do not represent the relative impedance values as
in an EIT image.
The normalized frequency distribution of regional MEF25/
MEF75 is plotted in Fig. 6. The patients in the CF group have0.3
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Fig. 3. Comparison of GI index values at four lung volume levels at 25%, 50%,
75% and 100% of maximum inspiratory volume. CF: the GI values of 14
patients in the CF group; H: the GI of 14 healthy volunteers in the control
group. The red lines indicate the median. The boxes mark the quartiles while the
whiskers show the most extreme data values within 1.5 times the interquartile
range of the sample. **Pb0.01, 20% greater than the GI values of CF100. GI,
global inhomogeneity, CF, cystic fibrosis, H, healthy.lower regional MEF25/MEF75 and the ratio is mainly distributed
from 0.06 to 0.21. Less than 25% of pixels (median) have a
regional MEF25/MEF75 larger than 0.24, while over 80% of
pixels (median) of subjects in the control group have a ratio larger
than 0.3.4. Discussion
In the present pilot study, we found EIT being feasible to
capture ventilation inhomogeneity and regional obstructions in
CF patients. The decrease of GI index during forced inspiration
in CF patients indicates a more homogeneous ventilation
distribution with increasing inspiration time. A MEF25/MEF75
map calculated with relative impedance values visualizes
regional obstructions.
Spirometry has been used for lung function testing in
patients with obstructive airway diseases for a long time. It is a
useful low-cost tool without need of radiation exposure when
compared to chest radiography and CT. However, it measures
only global parameters and may be influenced by multiple
factors, e.g. cooperation of patients. Examination with CT
delivers detailed information about lung aeration in CF patients.
The frequent use of CT is, however, not suitable for patients. A
technique is therefore warranted which provides more regional
information than lung function tests and is less invasive than
CT, so that it can be frequently applied. Although EIT is
noninvasive and has been proved to be reliable, applications of
EIT in patients with CF are still missing. Hence, a new
application of EIT was attempted in the present study, which
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Fig. 4. Flow-volume curves of one CF patient, obtained from spirometry and EIT. a, b) global Flow-volume curves from spirometry and EIT, respectively. c,d) two
exemplary regional Flow-volume curves from EIT. AU: arbitrary unit.
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additional dynamic and regional information.
Gustafsson et al. suggested that ventilation inhomogeneity
based on multiple-breath inert gas washout may be better than
lung function test in detecting early CF lung disease [8].
Compared to multibreath washout technique and CT, EIT has
the advantage that it visualizes ventilation distribution with a
very good temporal resolution. Differences in ventilation
homogeneity between healthy volunteers and patients with
critical lung disease based on EIT have previously beenTable 1
Comparison of spirometry measurements from the CF patients and the healthy
controls.
Spirometric parameters CF group Control group p
FEV1 (%predicted) 59.9±21.2 96.2±12.8 b0.001
FVC (%predicted) 68.1±27.7 86.2±13.9 b0.05
MEF25 (%predicted) 23.1±18.3 130.0±39.1 b0.001
MEF75 (%predicted) 52.9±30.9 91.8±23.5 b0.001
MEF25/MEF75 0.15±0.09 0.46±0.15 b0.001
Data are presented as mean±SD. FEV1, forced expiratory volume in 1 s; FVC,
forced vital capacity; MEF25, MEF75 maximum expiratory flow at 25% or 75%
of vital capacity; %predicted, measured value divided by predicted value [24] in
percentage.reported [22]. Low within-subject coefficient of variation for
GI index in both groups indicates that the EIT measurements
and GI calculation are highly reproducible. The degree of
ventilation inhomogeneity is relatively high in CF patients
because of “mucus plugging” in the small airways. Unfortu-
nately, large inter-patient variability at low lung volume range
(Fig. 3, CF25) makes it hard to distinguish CF patients from
healthy subjects during tidal breathing, unlike our previous
study, where healthy subjects were compared to patients with
acute lung injury [22]. Due to chronic airway obstruction in CF
patients, it may take longer for air to distribute within their
lungs. During cycles of forced inspiration and expiration, there
should be more time for air distribution. Thus, we assessed the
changes of ventilation distribution with EIT during lung
function tests with data recordings performed during forced
breathing. As hypothesized, the EIT-based GI index demon-
strated ventilation inhomogeneity at the onset of forced
breathing in CF patients, while ventilation became more
homogeneous during the later phases of inspiration (Figs. 2
and 3). No significant changes of ventilation over the breathing
cycle were found in healthy volunteers.
MEF25/MEF75 measured by EIT was found to be highly
correlated with spirometry (r=0.83). Further, regional MEF25/
Fig. 5. Comparison of regional MEF25/MEF75 maps between a healthy subject (left) and a CF patient (right) during forced expiration. Color bars indicate the ratio
values in each pixel. Low MEF25/MEF75 values are marked in dark blue.
417Z. Zhao et al. / Journal of Cystic Fibrosis 11 (2012) 412–418MEF75 varied in different lung areas (Figs. 5 and 6). A low
MEF25/MEF75 value potentially indicates regional obstructions,
which can be easily recognized in the MEF25/MEF75 map.
Since CF is initially a disease of the airways that eventually
progresses to parenchymal destruction and the extent of
destructive process is not uniformly distributed but rather
varies between lung regions [7], such regional information
provided by EIT may be useful for monitoring disease
progression, e.g. during onset and recovery from a pulmonary
exacerbation as well as the effects of therapy.
One drawback in the current EIT devices is that they deliver
only relative impedance values which do not represent exact
volumes and flow rates. A direct comparison with spirometry
indices such as FEV1 is therefore not possible. Hahn et al.
proposed a promising technique for absolute EIT [25,26],
however, this technique has to be further developed before
applicable in clinical routine. In the present study, we extracted
the feature MEF25/MEF75 for comparison since MEF25 is
usually much lower in CF patients compared to healthy subjects<0.03 <0.09 <0.15 <0.21 <0.27 >=0.3
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Fig. 6. Normalized frequency distribution of regional MEF25/MEF75 for the
patients in the CF group (bar in light grey, median) and the volunteers in the
control group (bar in dark grey, median). Black lines on the bars indicate the
upper (75%) and lower (25%) quartiles of the frequency in the CF group and in
the control group.[7]. A high correlation with the spirometry indicates that the
MEF25/MEF75 measured with EIT is reliable and useful. In
further studies, equivalent spirometry indices in EIT should be
considered. Another limitation of the current EIT devices is that
the measurement was taken at one cross-sectional plane that is
about 40 mm thick close to the body surface and increases its
thickness towards the central region of the body. Although the
EIT measuring plane is much thicker than a plane in CT
imaging, it cannot be observed if the destroyed lung regions are
outside the measuring plane. In the present study, significant
differences among various regional parameters were found
between healthy volunteers and CF patients, which means that
the measuring plane of EIT was well selected and represented
global lung status. Reifferscheid et al. and Bikker et al. have
measured ventilation distribution at two thoracic levels in
healthy subjects and mechanically ventilated patients [27,28].
In clinical practice, it is feasible to perform EIT measurement at
two thoracic planes when necessary, since the measurement
itself is not complicated or time consuming, however, at present
such measurements cannot be performed in parallel. Three
dimensional EIT systems are being developed in several
research groups but not yet used in a clinical setting [29,30].
In the future, 3D EIT may also be a solution for monitoring the
entire lung. One limitation of this feasibility study is that only
limited number of patients were recruited for examination at
one time point. In further studies, the sensitivity of EIT in CF
patients should be investigated. The CF patients should also be
examined at different time points to verify the ability of EIT in
tracking disease progression over time.
5. Conclusion
Compared to the global parameters provided by spirometry,
EIT is able to deliver both global and regional information to
assess the airway obstruction in CF patients. Further, EIT is
able to capture the variation of ventilation homogeneity during
forced respiration in CF patients. This may be helpful in early
diagnosis of disease exacerbation. Based on these findings, EIT
has the potential to become an additional clinical examination
tool for CF patients.
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